|
|
Volumn , Issue 41, 1994, Pages 269-279
|
|
Can our knowledge of monoamine oxidase (MAO) help in the design of better MAO inhibitors?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 ETHYLPHENOXATHIIN 10,10 DIOXIDE;
AMINE OXIDASE (FLAVIN CONTAINING);
BEFLOXATONE;
HARMALINE;
LAZABEMIDE;
MOCLOBEMIDE;
MONOAMINE OXIDASE INHIBITOR;
N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE;
ANIMAL TISSUE;
CONFERENCE PAPER;
DRUG DESIGN;
EPILEPSY;
NONHUMAN;
PRIORITY JOURNAL;
STROKE;
ANIMAL;
CHEMISTRY;
HUMAN;
REVIEW;
STEREOISOMERISM;
ANIMAL;
CHEMISTRY, PHARMACEUTICAL;
HUMAN;
MONOAMINE OXIDASE;
MONOAMINE OXIDASE INHIBITORS;
STEREOISOMERISM;
|
|
EID: 0028182788
PISSN: 03036995
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-3-7091-9324-2_35 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
